Clinical Trial Update: Secondary Use of PARALLEL-HF Data

View source ↗

Summary

A clinical trial update describing the secondary use of PARALLEL-HF data, focusing on chronic heart failure with reduced ejection fraction (HFrEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Heart Failure and Reduced Ejection Fraction (HFrEF) | Status: COMPLETED